声明：因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文仅作医疗健康相关药物介绍，非治疗方案推荐（若涉及）;本文不构成任何投资建议。2025年6月9日，美国生物遗传学公司Klotho Neurosciences（KLTO）宣布了积极的临床前数据，通过AAV9载体递送分泌型Klotho蛋白（s-KL）可有效增加小鼠血清中s-KL的浓度，使其寿命延长20%。此外，提高Klotho基因表达...
Source Link声明：因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文仅作医疗健康相关药物介绍，非治疗方案推荐（若涉及）;本文不构成任何投资建议。2025年6月9日，美国生物遗传学公司Klotho Neurosciences（KLTO）宣布了积极的临床前数据，通过AAV9载体递送分泌型Klotho蛋白（s-KL）可有效增加小鼠血清中s-KL的浓度，使其寿命延长20%。此外，提高Klotho基因表达...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.